Potential for cholesterol lowering in secondary prevention of coronary heart disease in Europe: findings from EUROASPIRE study

This publication has 22 references indexed in Scilit:

• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• EUROASPIRE: A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results
  European Heart Journal, 1997
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).
  Heart, 1996
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
  The Lancet, 1994
• Prevention of coronary heart disease in clinical practice
  European Heart Journal, 1994
• National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).
  Circulation, 1994
• Retardation and arrest of progression or regression of coronary artery disease: A review
  Progress in Cardiovascular Diseases, 1993
• The Value of Lowering Cholesterol after Myocardial Infarction
  New England Journal of Medicine, 1990